We are live on ! Find out more
CINC

CinCor Pharma, Inc. Common Stock
CINC

Delisted

CINC was delisted on the 23rd of February, 2023.

Back to rankings

57 hedge funds and large institutions have $596M invested in CinCor Pharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

100% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 12

15% more capital invested

Capital invested by funds: $520M → $596M (+$75.8M)

8% more funds holding

Funds holding: 53 → 57 (+4)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
57
Holders Change
+4
Holders Change %
+7.55%
% of All Funds
0.96%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
9
Increased
24
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$11.3M
2
DCM
Driehaus Capital Management
Illinois
+$9.33M
3
JP Morgan Chase
JP Morgan Chase
New York
+$3.62M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.38M
5
BlackRock
BlackRock
New York
+$3.18M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$1.74M
2
CCM
CAAS Capital Management
New York
-$1.32M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$751K
4
PHK
Point72 Hong Kong
Hong Kong
-$387K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$334K
Name Holding Trade Value Shares
Change 		Change in
Stake
IHAM
26
Integral Health Asset Management
New York
$787K +$799K +41,748 New
Manulife (Manufacturers Life Insurance)
27
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$766K +$289K +15,113 +50%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$655K +$49.5K +2,586 +8%
Swiss National Bank
29
Swiss National Bank
Switzerland
$586K +$595K +31,100 New
Walleye Capital
30
Walleye Capital
New York
$552K +$20.5K +1,073 +4%
Bank of America
31
Bank of America
North Carolina
$497K +$327K +17,085 +184%
Morgan Stanley
32
Morgan Stanley
New York
$434K +$384K +20,040 +659%
LP
33
LMR Partners
United Kingdom
$432K -$143K -7,488 -25%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$360K +$366K +19,105 New
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$330K -$334K -17,424 -50%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$321K +$231K +12,088 +245%
CSS
37
Cubist Systematic Strategies
Connecticut
$215K +$184K +9,600 +533%
Goldman Sachs
38
Goldman Sachs
New York
$202K -$54K -2,821 -21%
CS
39
Credit Suisse
Switzerland
$192K +$195K +10,193 New
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$180K +$1.47K +77 +0.8%
MIM
41
MetLife Investment Management
New Jersey
$152K – – –
AIG
42
American International Group
New York
$118K +$9.78K +511 +9%
Deutsche Bank
43
Deutsche Bank
Germany
$107K -$21.5K -1,124 -17%
Osaic Holdings
44
Osaic Holdings
Arizona
$95K +$89.5K +4,676 New
Legal & General Group
45
Legal & General Group
United Kingdom
$81K +$61.9K +3,231 +293%
SO
46
STRS Ohio
Ohio
$50K – – –
AB
47
Amalgamated Bank
New York
$40K -$3.22K -168 -7%
Citigroup
48
Citigroup
New York
$24K +$4.96K +259 +25%
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$17.9K – – –
UBS Group
50
UBS Group
Switzerland
$16K -$24.6K -1,283 -60%
1
2
3

CINC Hedge Fund Activity: Q2 2022 in Review

57 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in CinCor Pharma, Inc. Common Stock (CINC) for Q2 2022, worth a combined $596M — up 15% from $520M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CINC positions and 4 closed out — a net gain of 5 holders — while 24 added to existing stakes and 12 trimmed.

The largest buyer was Great Point Partners, adding an estimated $11.3M. The largest seller was BVF Inc, cutting an estimated $1.74M.

  • 57 institutional investors held CinCor Pharma, Inc. Common Stock (CINC) as of Q2 2022, up from 53 in Q1 2022.
  • Funds reported $596M of CinCor Pharma, Inc. Common Stock stock for Q2 2022, up 15% quarter-over-quarter.
  • 9 funds opened new CinCor Pharma, Inc. Common Stock positions in Q2 2022 and 4 closed out, a net change of +5 holders.
  • The largest CinCor Pharma, Inc. Common Stock buyer in Q2 2022 was Great Point Partners, an estimated $11.3M added.
  • The largest CinCor Pharma, Inc. Common Stock seller in Q2 2022 was BVF Inc, an estimated $1.74M sold.

Based on aggregated 13F filings for Q2 2022.